You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JNJ-54767414

Showing 1 - 25 of 458
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)

Completed
Has Results
  • Multiple Myeloma
  • Antwerpen, Belgium
  • +12 more
Dec 1, 2022

High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

Completed
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Actinium Ac 225-DOTA-Daratumumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

Not yet recruiting
  • AL Amyloidosis
  • Bone Marrow Biopsy
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Jun 2, 2023

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Recurrent Plasma Cell Myeloma Trial in Houston (Daratumumab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2021

Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

Active, not recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 25, 2022

Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Multiple Myeloma Trial in China (Daratumumab)

Completed
  • Multiple Myeloma
  • Beijing, China
  • +4 more
Nov 12, 2020

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Active, not recruiting
  • Plasma Cell Myeloma
  • Daratumumab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)

Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
Dec 27, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

Recurrent Plasma Cell Myeloma Trial in United States (Daratumumab, Dexamethasone, Pomalidomide)

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • +2 more
  • Wichita, Kansas
  • +4 more
Jun 13, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Belantamab Mafodotin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 10, 2022

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Multiple Myeloma Trial in Rochester (procedure, biological, drug)

Not yet recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +12 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 15, 2023